International Society for Heart and Lung Transplantation

Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement

2026InternationalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

International

Read the PDF Original at the sourceAsk Osler about this guideline

Read the guideline

Full guideline, as published636 KBOpen in a new tab Download

Open the PDF

Source and rights

Published by The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2026. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

www.jhltonline.org/article/S1053-2498(25)02282-X/pdf

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Organisation: International Society for Heart and Lung Transplantation
Published: 2026
Applies to: 🌐 International
Scope: International
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
DOI: 10.1016/j.healun.2025.09.016
PubMed: 41548963
Added to Prognia: 18 July 2026

Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHCGlobal Initiative for Asthma · 2026Added 29 Jul 2026PodcastInfographic